Psychiatry and Neurology, Neurology · Newburgh, NY
NPI
1669587093
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
5159 Route 9w, Suite B
Newburgh, NY, 12550
Phone (845) 561-5972
Medicare paid, 2024
$847K
9,790 services
Medicare patients, 2024
1,492
Average age 76
Drug cost, 2024
$501K
5,952 prescriptions
Company payments, 2025
$416
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed Nasir was code 99233 (hospital e&m - subsequent), 2,825 times for 850 patients. In total Syed Nasir billed 9,790 services in 25 codes, and Medicare paid $847K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 2,825 | 850 | $96.96 | $274K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,545 | 554 | $12.89 | $20K |
| 99232 Hospital E&M - Subsequent | Facility | 1,464 | 501 | $64.28 | $94K |
| 99214 Office E&M - Established | Office | 1,134 | 478 | $96.05 | $109K |
| 99223 Hospital E&M - Initial | Facility | 826 | 756 | $138.98 | $115K |
| 99215 Office E&M - Established | Office | 449 | 303 | $139.89 | $63K |
| 99213 Office E&M - Established | Office | 260 | 184 | $72.32 | $19K |
| 93886 Ultrasound - Nonspecific | Office | 152 | 149 | $229.41 | $35K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 151 | 148 | $128.02 | $19K |
| 99222 Hospital E&M - Initial | Facility | 149 | 144 | $103.47 | $15K |
| 93925 Duplex Scan - Extremity Arteries | Office | 147 | 144 | $165.35 | $24K |
| 99497 Care Management/Coordination | Office | 147 | 139 | $63.51 | $9,336 |
| 99212 Office E&M - Established | Office | 130 | 128 | $46.23 | $6,010 |
| 95886 Electrical Nerve Conductivity | Office | 128 | 63 | $79.63 | $10K |
| 99204 Office E&M - New | Office | 88 | 88 | $124.41 | $11K |
By year: 2022 $788K for 7,921 services; 2023 $764K for 7,564 services; 2024 $847K for 9,790 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed Nasir prescribed most often to Medicare patients was Memantine Hcl, with 470 prescriptions and refills. In total Syed Nasir wrote 5,952 Medicare prescriptions that cost $501K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 470 | 630 | 95 | $16K |
| Gabapentin Generic | 454 | 594 | 97 | $5,051 |
| Rivastigmine Rivastigmine Tartrate | 440 | 604 | 82 | $20K |
| Levetiracetam Generic | 395 | 500 | 52 | $16K |
| Levetiracetam Er Levetiracetam | 258 | 410 | 47 | $14K |
| Pregabalin Generic | 255 | 268 | 45 | $3,719 |
| Citalopram Hbr Citalopram Hydrobromide | 233 | 319 | 43 | $1,040 |
| Donepezil Hcl Generic | 191 | 275 | 36 | $1,423 |
| Quetiapine Fumarate Generic | 187 | 239 | 33 | $2,949 |
| Topiramate Generic | 182 | 206 | 39 | $2,244 |
| Clopidogrel Clopidogrel Bisulfate | 169 | 295 | 40 | $1,353 |
| Rivastigmine Generic | 160 | 240 | 36 | $27K |
| Memantine Hcl Er Memantine Hcl | 158 | 215 | 31 | $15K |
| Meclizine Hcl Generic | 142 | 160 | 50 | $1,585 |
| Aspirin-Dipyridamole Er Aspirin/Dipyridamole | 116 | 222 | 35 | $20K |
Brand drugs: 204 claims; generic drugs: 5,702 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed Nasir $416 ($416 in general payments such as food, travel and fees) from 1 company. The largest payer was Teva Pharmaceuticals USA, Inc. with $416.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 20 | $416 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.